Antisense and RNAi Therapeutics Market Report

Global Antisense and RNAi Therapeutics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Dec 29, 2020
  • PAGES：146
  • REPORT CODE：GMM604480
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology.

    The potential commercialization of a few candidates under research and development will help the antisense and RNAi therapeutics market to pick up pace in North America in the near future.

    The Antisense and RNAi Therapeutics is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period. The research provides insights for the global Antisense and RNAi Therapeutics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Antisense and RNAi Therapeutics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Antisense and RNAi Therapeutics Market Segmentations:

    By Players:

    • Roche

    • Tekmira Pharmaceuticals

    • Alnylam Pharmaceuticals

    • Silence Therapeutics

    • Sirnaomics

    • Antisense Therapeutics

    • Arbutus Biopharma

    • Santaris

    • Isis Pharmaceuticals

    By Types:

    • RNA Interference

    • Antisense RNA

    By End-User:

    • Hospital

    • Clinic

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Antisense and RNAi Therapeutics Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Antisense and RNAi Therapeutics Market Size and Growth Rate of RNA Interference from 2014 to 2026

      • 1.3.2 Global Antisense and RNAi Therapeutics Market Size and Growth Rate of Antisense RNA from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Antisense and RNAi Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.2 Global Antisense and RNAi Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Antisense and RNAi Therapeutics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Antisense and RNAi Therapeutics Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Antisense and RNAi Therapeutics by Major Types

      • 3.4.1 Antisense and RNAi Therapeutics Market Size and Growth Rate of RNA Interference

      • 3.4.2 Antisense and RNAi Therapeutics Market Size and Growth Rate of Antisense RNA

    4 Segmentation of Antisense and RNAi Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Antisense and RNAi Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Antisense and RNAi Therapeutics in Hospital

      • 4.4.2 Market Size and Growth Rate of Antisense and RNAi Therapeutics in Clinic

    5 Market Analysis by Major Regions

    • 5.1 Global Antisense and RNAi Therapeutics Production Analysis by Major Regions

    • 5.2 Global Antisense and RNAi Therapeutics Consumption Analysis by Major Regions

    • 5.3 Global Antisense and RNAi Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Antisense and RNAi Therapeutics Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Antisense and RNAi Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Antisense and RNAi Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Antisense and RNAi Therapeutics Production, Import, Consumption and Export Analysis

    6 Product Commodity of Antisense and RNAi Therapeutics Market in Major Countries

    • 6.1 Top 5 Export Countries in Antisense and RNAi Therapeutics market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Antisense and RNAi Therapeutics market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Antisense and RNAi Therapeutics market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Antisense and RNAi Therapeutics market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Antisense and RNAi Therapeutics market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Antisense and RNAi Therapeutics market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Antisense and RNAi Therapeutics Landscape Analysis

    • 7.1 North America Antisense and RNAi Therapeutics Landscape Analysis by Major Types

    • 7.2 North America Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users

    • 7.3 North America Antisense and RNAi Therapeutics Landscape Analysis by Major Countries

      • 7.3.1 United States Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 7.3.2 Canada Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 7.3.3 Mexico Antisense and RNAi Therapeutics Market Volume and Growth Rate

    8 Europe Antisense and RNAi Therapeutics Landscape Analysis

    • 8.1 Europe Antisense and RNAi Therapeutics Landscape Analysis by Major Types

    • 8.2 Europe Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users

    • 8.3 Europe Antisense and RNAi Therapeutics Landscape Analysis by Major Countries

      • 8.3.1 Germany Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.2 UK Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.3 France Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.4 Italy Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.6 Spain Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.7 Belgium Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.8 Poland Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.9 Russia Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 8.3.10 Turkey Antisense and RNAi Therapeutics Market Volume and Growth Rate

    9 Asia Pacific Antisense and RNAi Therapeutics Landscape Analysis

    • 9.1 Asia Pacific Antisense and RNAi Therapeutics Landscape Analysis by Major Types

    • 9.2 Asia Pacific Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Antisense and RNAi Therapeutics Landscape Analysis by Major Countries

      • 9.3.1 China Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 9.3.2 Japan Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 9.3.4 India Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 9.3.6 South Korea Antisense and RNAi Therapeutics Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Antisense and RNAi Therapeutics Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Antisense and RNAi Therapeutics Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Antisense and RNAi Therapeutics Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Antisense and RNAi Therapeutics Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 10.3.2 Brazil Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 10.3.3 Nigeria Antisense and RNAi Therapeutics Market Volume and Growth Rate

      • 10.3.4 South Africa Antisense and RNAi Therapeutics Market Volume and Growth Rate 

      • 10.3.5 Argentina Antisense and RNAi Therapeutics Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Roche

      • 11.1.1 Roche Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Tekmira Pharmaceuticals

      • 11.2.1 Tekmira Pharmaceuticals Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Alnylam Pharmaceuticals

      • 11.3.1 Alnylam Pharmaceuticals Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Silence Therapeutics

      • 11.4.1 Silence Therapeutics Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Sirnaomics

      • 11.5.1 Sirnaomics Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Antisense Therapeutics

      • 11.6.1 Antisense Therapeutics Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Arbutus Biopharma

      • 11.7.1 Arbutus Biopharma Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Santaris

      • 11.8.1 Santaris Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Isis Pharmaceuticals

      • 11.9.1 Isis Pharmaceuticals Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 84 Figures and 150 Tables)

    • Figure Product Picture

    • Figure Antisense and RNAi Therapeutics Market Size and Growth Rate of RNA Interference from 2014 to 2026

    • Figure Antisense and RNAi Therapeutics Market Size and Growth Rate of Antisense RNA from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Antisense and RNAi Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Global Antisense and RNAi Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Antisense and RNAi Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Antisense and RNAi Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Antisense and RNAi Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Antisense and RNAi Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of Antisense and RNAi Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of RNA Interference

    • Figure Market Size and Growth Rate of Antisense RNA

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Antisense and RNAi Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Antisense and RNAi Therapeutics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Table Global Antisense and RNAi Therapeutics Production by Major Regions

    • Table Global Antisense and RNAi Therapeutics Production Share by Major Regions

    • Figure Global Antisense and RNAi Therapeutics Production Share by Major Regions in 2014

    • Figure Global Antisense and RNAi Therapeutics Production Share by Major Regions in 2018

    • Figure Global Antisense and RNAi Therapeutics Production Share by Major Regions in 2026

    • Table Global Antisense and RNAi Therapeutics Consumption by Major Regions

    • Table Global Antisense and RNAi Therapeutics Consumption Share by Major Regions

    • Figure Global Antisense and RNAi Therapeutics Consumption Share by Major Regions in 2014

    • Figure Global Antisense and RNAi Therapeutics Consumption Share by Major Regions in 2018

    • Figure Global Antisense and RNAi Therapeutics Consumption Share by Major Regions in 2026

    • Table North America Antisense and RNAi Therapeutics Production, Import, Consumption and Export Analysis

    • Table Europe Antisense and RNAi Therapeutics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Antisense and RNAi Therapeutics Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Antisense and RNAi Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Antisense and RNAi Therapeutics market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Antisense and RNAi Therapeutics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Antisense and RNAi Therapeutics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Antisense and RNAi Therapeutics market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026

    • Table North America Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure North America Antisense and RNAi Therapeutics Consumption Share by Types in 2014

    • Figure North America Antisense and RNAi Therapeutics Consumption Share by Types in 2018

    • Figure North America Antisense and RNAi Therapeutics Consumption Share by Types in 2026

    • Table North America Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026

    • Table North America Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure North America Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014

    • Figure North America Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018

    • Figure North America Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026

    • Table North America Antisense and RNAi Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table North America Antisense and RNAi Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2014

    • Figure North America Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2018

    • Figure North America Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2026

    • Figure United States Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026

    • Table Europe Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Europe Antisense and RNAi Therapeutics Consumption Share by Types in 2014

    • Figure Europe Antisense and RNAi Therapeutics Consumption Share by Types in 2018

    • Figure Europe Antisense and RNAi Therapeutics Consumption Share by Types in 2026

    • Table Europe Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Europe Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014

    • Figure Europe Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018

    • Figure Europe Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026

    • Table Europe Antisense and RNAi Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Europe Antisense and RNAi Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2014

    • Figure Europe Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2018

    • Figure Europe Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2026

    • Figure Germany Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure France Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026

    • Table Asia Pacific Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Antisense and RNAi Therapeutics Consumption Share by Types in 2014

    • Figure Asia Pacific Antisense and RNAi Therapeutics Consumption Share by Types in 2018

    • Figure Asia Pacific Antisense and RNAi Therapeutics Consumption Share by Types in 2026

    • Table Asia Pacific Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014

    • Figure Asia Pacific Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018

    • Figure Asia Pacific Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026

    • Table Asia Pacific Antisense and RNAi Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Antisense and RNAi Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2026

    • Figure China Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandAntisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure India Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Antisense and RNAi Therapeutics Consumption Share by Major Countries in 2026

    • Figure GCC Countries Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Antisense and RNAi Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Tekmira Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tekmira Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Tekmira Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Tekmira Pharmaceuticals

    • Table Product and Service Introduction of Tekmira Pharmaceuticals

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Product and Service Introduction of Alnylam Pharmaceuticals

    • Table Company Profile and Development Status of Silence Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics

    • Figure Sales and Growth Rate Analysis of Silence Therapeutics

    • Figure Revenue and Market Share Analysis of Silence Therapeutics

    • Table Product and Service Introduction of Silence Therapeutics

    • Table Company Profile and Development Status of Sirnaomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sirnaomics

    • Figure Sales and Growth Rate Analysis of Sirnaomics

    • Figure Revenue and Market Share Analysis of Sirnaomics

    • Table Product and Service Introduction of Sirnaomics

    • Table Company Profile and Development Status of Antisense Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antisense Therapeutics

    • Figure Sales and Growth Rate Analysis of Antisense Therapeutics

    • Figure Revenue and Market Share Analysis of Antisense Therapeutics

    • Table Product and Service Introduction of Antisense Therapeutics

    • Table Company Profile and Development Status of Arbutus Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arbutus Biopharma

    • Figure Sales and Growth Rate Analysis of Arbutus Biopharma

    • Figure Revenue and Market Share Analysis of Arbutus Biopharma

    • Table Product and Service Introduction of Arbutus Biopharma

    • Table Company Profile and Development Status of Santaris

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Santaris

    • Figure Sales and Growth Rate Analysis of Santaris

    • Figure Revenue and Market Share Analysis of Santaris

    • Table Product and Service Introduction of Santaris

    • Table Company Profile and Development Status of Isis Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Isis Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Isis Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Isis Pharmaceuticals

    • Table Product and Service Introduction of Isis Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US